Plerixafor Accord Europska Unija - hrvatski - EMA (European Medicines Agency)

plerixafor accord

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - Иммуностимуляторы, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.

Dimethyl fumarate Accord Europska Unija - hrvatski - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetil fumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresivi - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Degarelix Accord Europska Unija - hrvatski - EMA (European Medicines Agency)

degarelix accord

accord healthcare s.l.u. - degarelix acetate - prostatske neoplazme - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Irinotekan Accord 20 mg/ml koncentrat za otopinu za infuziju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

irinotekan accord 20 mg/ml koncentrat za otopinu za infuziju

accord healthcare polska sp. z o.o., ul. tasmowa 7, mazowieckie, varšava, poljska - irinotekanklorid trihidrat - koncentrat za otopinu za infuziju - 20 mg/ml - urbroj: 1 ml koncentrata sadrži 20 mg irinotekanklorid trihidrata, što odgovara 17,33 mg irinotekana

Lopinavir/ritonavir Accord 200 mg/50 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

lopinavir/ritonavir accord 200 mg/50 mg filmom obložene tablete

accord healthcare polska sp. z o.o., ul. tasmowa 7, mazowieckie, varšava, poljska - lopinavir ritonavir - filmom obložena tableta - 200 mg + 50 mg - urbroj: svaka filmom obložena tableta sadrži 200 mg lopinavira u kombinaciji s 50 mg ritonavira, kao farmakokinetičkog pojačivača

Ritonavir Accord 100 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

ritonavir accord 100 mg filmom obložene tablete

accord healthcare polska sp. z o.o., ul. tasmowa 7, mazowieckie, varšava, poljska - ritonavir - filmom obložena tableta - 100 mg - urbroj: jedna filmom obložena tableta sadrži 100 mg ritonavira

Atazanavir Accord 150 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

atazanavir accord 150 mg tvrde kapsule

accord healthcare polska sp. z o.o., ul. tasmowa 7, mazowieckie, varšava, poljska - atazanavirsulfat - kapsula, tvrda - 150 mg - urbroj: jedna kapsula sadrži 100 mg atazanavirsulfata, što odgovara 150 mg atazanavira

Atazanavir Accord 200 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

atazanavir accord 200 mg tvrde kapsule

accord healthcare polska sp. z o.o., ul. tasmowa 7, mazowieckie, varšava, poljska - atazanavirsulfat - kapsula, tvrda - 200 mg - urbroj: jedna kapsula sadrži 100 mg atazanavirsulfata, što odgovara 200 mg atazanavira

Atazanavir Accord 300 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

atazanavir accord 300 mg tvrde kapsule

accord healthcare polska sp. z o.o., ul. tasmowa 7, mazowieckie, varšava, poljska - atazanavirsulfat - kapsula, tvrda - 300 mg - urbroj: jedna kapsula sadrži 100 mg atazanavirsulfata, što odgovara 300 mg atazanavira

Ambrisentan Accord 5 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

ambrisentan accord 5 mg filmom obložene tablete

accord healthcare polska sp. z o.o., ul. tasmowa 7, mazowieckie, varšava, poljska - ambrisentan - filmom obložena tableta - 5 mg - urbroj: jedna tableta sadrži 5 mg ambrisentana